Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 5/20 | 0.35 |
| ▸ | DRD2 | P14416 | 5/20 | 0.35 |
| ▸ | DRD4 | P21917 | 5/20 | 0.35 |
| ▸ | DRD3 | P35462 | 5/20 | 0.35 |
| ▸ | HTR1A | P08908 | 4/20 | 0.33 |
| ▸ | HTR1D | P28221 | 4/20 | 0.33 |
| ▸ | HTR1B | P28222 | 4/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.31 |
| ▸ | DRD5 | P21918 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL903731 | 0.82 | ALDH1A1 (0.43) | — | |
| SCHEMBL903733 | 0.72 | WEE1 (0.40) | — | |
| SCHEMBL6280229 | 0.69 | TP53 (0.41) | CNR2CNR1CHRM1DRD2DRD4 | |
| SCHEMBL27788934 | 0.68 | PPARA (0.43) | CNR2CNR1CHRM1DRD2DRD4 | |
| SCHEMBL904323 | 0.66 | DRD2 (0.39) | CHRM1DRD2DRD4DRD3HTR1D | |
| SCHEMBL6103258 | 0.66 | HSD11B1 (0.41) | CNR2CNR1CHRM1DRD2DRD4 | |
| SCHEMBL12082049 | 0.65 | PPARG (0.47) | CNR2CNR1CHRM1DRD2DRD4 | |
| SCHEMBL12602178 | 0.65 | CHRM1 (0.42) | CHRM1DRD2DRD4DRD3 | |
| SCHEMBL8172360 | 0.65 | ALDH1A1 (0.44) | — | |
| SCHEMBL22449626 | 0.65 | ALDH1A1 (0.47) | CNR2DRD2DRD3HTR1DHSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012040924-A1 | FUSED TETRACYCLIC HETEROCYCLE COMPOUNDS AND METHODS OF USE THEREOF FOR TREATMENT OF VIRAL DISEASES | MERCK SHARP & DOHME CORP. (US) | 2012-04-05 | — | — | WO | disclosed |
| WO-2012041227-A1 | TETRACYCLIC HETEROCYCLE COMPOUNDS FOR TREATING HEPATITIS C VIRAL INFECTION | MERCK SHARP & DOHME CORP. (US) | 2012-04-05 | — | — | WO | disclosed |